STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
SplitMay 7, 2026, 09:02 AM

KALA BIO Announces 1-for-50 Reverse Stock Split

AI Summary

KALA BIO, Inc. announced its intention to effect a 1-for-50 reverse stock split of its common stock, effective May 8, 2026, with split-adjusted trading commencing May 11, 2026. This action, authorized by stockholders on January 30, 2026, will reduce the number of outstanding shares from approximately 929.5 million to 18.6 million. Fractional shares will be compensated with cash payments, and proportional adjustments will be made to all equity awards and convertible securities.

Key Highlights

  • KALA BIO announced a 1-for-50 reverse stock split of its common stock.
  • The reverse stock split will become effective at 4:05 p.m. on Friday, May 8, 2026.
  • Common stock will begin trading on a split-adjusted basis on Monday, May 11, 2026.
  • The new CUSIP number for the common stock following the reverse stock split is 483119301.
  • Outstanding shares will be reduced from 929,491,578 to approximately 18,589,832.
  • Stockholders holding fractional shares will receive a cash payment based on the May 7, 2026 closing price.
  • Proportional adjustments will be made to equity awards, warrants, and other convertible securities.
KALA
Biotechnology: Pharmaceutical Preparations
KALA BIO, Inc.

Price Impact